arrow
Back
I

Indira Brar

michigan state university

23H-index
126Paper Count
4.1KCitation Count
Published Papers 23
Publication Date
Implementation of a Best Practice Advisory–Based HIV Screening Program in the Emergency Department with Integrated Infectious Diseases: A Descriptive Study
err2026-08-07
err0
errOAAI
errBrianna Hohmann; Madison Patrus; Smitha Gudipati; Thomas Hagerman; Nicholas Yared; Dalton Bender; Shannon Payne; Jun Jin; Jacob Manteuffel; Indira Brar; null
errShare
errSave
Renal Outcomes in People With HIV-1 and Renal Impairment Treated With B/F/TAF: Integrated Analysis from Nine Phase 3/3b Clinical Trials
err2026-05-04
err0
errOAAI
errFrank A Post; David Wohl; Geoffroy Liegeon; Indira Brar; Debbie Hagins; Yazdan Yazdanpanah; Anchalee Avihingsanon; Hui Liu; Keith Aizen; Jason T Hindman; Samir Gupta
errShare
errSave
A cross-sectional analysis of doxyPEP use and outcomes in Michigan, United States
err2025-09-01
err0
PREAI
errArena, Christen J.; Everson, Nathan A.; Kenney, Rachel M.; Brar, Indira; Gudipati, Smitha; Yared, Nicholas; Davis, Susan L.; Veve, Michael P.
errShare
errSave
errShare
errSave
Effects of antiretrovirals on major adverse cardiovascular events in the REPRIEVE trial: a longitudinal cohort analysis
err2025-06-04
err0
PREAI
errCarl J Fichtenbaum; Carlos D Malvestutto; Maya G Watanabe; Emma Davies Smith; Heather J Ribaudo; Sara McCallum; Kathleen V Fitch; Judith S Currier; Marissa R Diggs; Sarah M Chu; Judith A Aberg; Michael T Lu; Javier Valencia; Cristina Gómez-Ayerbe; Indira Brar; Jose Valdez Madruga; Gerald S Bloomfield; Pamela S Douglas; Markella V Zanni; Steven K Grinspoon
errShare
errSave
Cardiovascular Hazards of Abacavir- Versus Tenofovir-Containing Antiretroviral Therapies: Insights From an Analysis of the REPRIEVE Trial Cohort
err2025-04-01
err0
errOAAI
errSmith, Emma Davies; Malvestutto, Carlos; Ribaudo, Heather J.; Fichtenbaum, Carl J.; Aberg, Judith A.; Watanabe, Maya; Bloomfield, Gerald S.; Currier, Judith S.; Chu, Sarah M.; Fitch, Kathleen, V; Diggs, Marissa R.; Bedimo, Roger; Valencia, Javier; Gomez-Ayerbe, Cristina; Brar, Indira; Madruga, Jose Valdez; Lu, Michael T.; Douglas, Pamela S.; Zanni, Markella, V; Grinspoon, Steven K.
errShare
errSave
Vaccine coverage and factors associated with vaccine adherence in persons with HIV at an urban infectious disease clinic
err2023-04-27
err3
errOAAI
errBirk, Navina K.; Monday, Lea; Singh, Tarandeep; Cherabuddi, Medha; Hojeij, Marwa; Ho, Brandon; Chen, Anne; Brar, Indira; Alangaden, George
errShare
errSave
Evaluating the Impact of Substance Use Disorder Resources on Outcomes of Persons Who Inject Drugs with Infections
err2022-07-06
err0
PREAI
errGreenlee, Sage B.; Kenney, Rachel M.; Makowski, Charles T.; Bulat, Elizabeth; Brar, Indira; Davis, Susan L.
errShare
errSave
Papillomatous Anogenital Lesions in a Patient With Human Immunodeficiency Virus
err2022-06-23
err1
errOAAI
errFernandez, Omar E.; Gudipati, Smitha; Ko, Dayoung; Boucher, Alison; Brar, Indira
errShare
errSave
Progression to Critical Illness and Death in Patients With Breakthrough Hospitalizations
err2022-04-21
err6
errOAAI
errSuleyman, Geehan; Fadel, Raef; Alsaadi, Ayman; Sueng, Luis Ng; Ghandour, Ali; Alkhatib, Ahmad; Singh, Tarandeep; Parsons, Austin; Miller, Joseph; Ramesh, Mayur; Brar, Indira; Alangaden, George
errShare
errSave
Risk Factors Associated With Hospitalization and Death in COVID-19 Breakthrough Infections
err2022-03-07
err20
errOAAI
errSuleyman, Geehan; Fadel, Raef; Brar, Indira; Kassab, Rita; Khansa, Rafa; Sturla, Nicholas; Alsaadi, Ayman; Latack, Katie; Miller, Joseph; Tibbetts, Robert; Samuel, Linoj; Alangaden, George; Ramesh, Mayur
errShare
errSave
The Impact of Sociodemographic Factors, Comorbidities, and Physiologic Responses on 30-Day Mortality in Coronavirus Disease 2019 (COVID-19) Patients in Metropolitan Detroit
err2020-09-18
err19
errOAAI
errMiller, Joseph; Fadel, Raef A.; Tang, Amy; Perrotta, Giuseppe; Herc, Erica; Soman, Sandeep; Nair, Sashi; Hanna, Zachary; Zervos, Marcus J.; Alangaden, George; Brar, Indira; Suleyman, Geehan
errShare
errSave
Rapid Reorganization of an Academic Infectious Diseases Program During the Coronavirus Disease 2019 Pandemic in Detroit: A Novel Unit-based Group Rounding Model
err2020-07-01
err1
errOAAI
errVahia, Amit T.; Chaudhry, Zohra S.; Kaljee, Linda; Parraga-Acosta, Tommy; Gudipati, Smitha; Maki, Gina; Tariq, Zain; Shallal, Anita; Nauriyal, Varidhi; Williams, Jonathan D.; Suleyman, Geehan; Abreu-Lanfranco, Odaliz; Chen, Anne; Yared, Nicholas; Herc, Erica; McKinnon, John E.; Brar, Indira; Bhargava, Pallavi; Zervos, Marcus; Ramesh, Mayur; Alangaden, George
errShare
errSave
errShare
errSave
Switching to fixed-dose bictegravir, emtricitabine, and tenofovir alafenamide from dolutegravir plus abacavir and lamivudine in virologically suppressed adults with HIV-1: 48 week results of a randomised, double-blind, multicentre, active-controlled, phase 3, non-inferiority trial
err2018-07-01
err139
PREAI
errMolina, Jean-Michel; Ward, Douglas; Brar, Indira; Mills, Anthony; Stellbrink, Hans Juergen; Lopez-Cortes, Luis; Ruane, Peter; Podzamczer, Daniel; Brinson, Cynthia; Custodio, Joseph; Liu, Hui; Andreatta, Kristen; Martin, Hal; Cheng, Andrew; Quirk, Erin
errShare
errSave
Bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir, abacavir, and lamivudine for initial treatment of HIV-1 infection (GS-US-380-1489): a double-blind, multicentre, phase 3, randomised controlled non-inferiority trial
errLANCET
IF88.5
err2017-11-01
err280
PREAI
errGallant, Joel; Lazzarin, Adriano; Mills, Anthony; Orkin, Chloe; Podzamczer, Daniel; Tebas, Pablo; Girard, Pierre-Marie; Brar, Indira; Daar, Eric S.; Wohl, David; Rockstroh, Juergen; Wei, Xuelian; Custodio, Joseph; White, Kirsten; Martin, Hal; Cheng, Andrew; Quirk, Erin
errShare
errSave
The Hepatitis C and HIV Co-Infected Patient: Time to Scale Up HCV Therapy at a Local Level
err2016-04-01
err0
PREAI
errMeighani, Alireza; Bourgi, Kassem; Bajoka, Rebecca; Alsafadi, Muhammad; Brar, Indira
errShare
errSave
Switching from tenofovir disoproxil fumarate to tenofovir alafenamide in antiretroviral regimens for virologically suppressed adults with HIV-1 infection: a randomised, active-controlled, multicentre, open-label, phase 3, non-inferiority study
err2016-01-01
err267
errOAAI
errMills, Anthony; Arribas, Jose R.; Andrade-Villanueva, Jaime; DiPerri, Giovanni; Van Lunzen, Jan; Koenig, Ellen; Elion, Richard; Cavassini, Matthias; Madruga, Jose Valdez; Brunetta, Jason; Shamblaw, David; DeJesus, Edwin; Orkin, Chloe; Wohl, David A.; Brar, Indira; Stephens, Jeffrey L.; Girard, Pierre-Marie; Huhn, Gregory; Plummer, Andrew; Liu, Ya-Pei; Cheng, Andrew K.; McCallister, Scott
errShare
errSave
Interruption or deferral of antiretroviral therapy reduces markers of bone turnover compared with continuous therapy: The SMART body composition substudy
err2013-01-08
err32
errOAAI
errHoy, Jennifer; Grund, Birgit; Roediger, Mollie; Ensrud, Kristine E.; Brar, Indira; Colebunders, Robert; De Castro, Nathalie; Johnson, Margaret; Sharma, Anjali; Carr, Andrew
errShare
errSave
HCV Enters the Twenty-First Century
err2012-12-21
err1
errOAAI
errBrar, Indira; Baxa, Dwayne; Markowitz, Norman
errShare
errSave